Status:
UNKNOWN
Role of Prophylactic Biliary Stent in Reducing the Recurrence of Choledocholithiasis
Lead Sponsor:
Asian Institute of Gastroenterology, India
Conditions:
Choledocholithiasis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
We planned this multicenter randomized controlled trial to study the role of a prophylactic biliary stent in recurrence of stones and biliary complications in patients awaiting cholecystectomy after b...
Detailed Description
Patients with cholelithiasis can have presence of concomitant choledocholithiasis (CDL) in upto 30%. These stones may remain asymptomatic or cause obstructive jaundice and complications like cholangit...
Eligibility Criteria
Inclusion
- Age between 18-80 years
- Cases of cholelithiasis with concomitant CDL in whom CBD clearance is achieved will be included.
Exclusion
- Informed consent not available
- Patients opting for single stage surgery
- Previous hepatobiliary surgery
- Failure to completely clear CDL on ERC
- Concomitant benign biliary strictures (like chronic pancreatitis, portal cavernoma cholangiopathy, post cholecystectomy, primary biliary cholangitis related)
- Previous cholecystectomy patients
- Associated malignancy
- Coagulopathy(INR\>1.5, platlets\<1lac)
- Severe cholangitis
Key Trial Info
Start Date :
September 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT06060002
Start Date
September 30 2023
End Date
December 30 2025
Last Update
September 29 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.